ahead of our upcoming meeting in March we have provided the FDA with new data
from a second potency assay that provides additional product characterization as requested by FDA.
Explain this?
- Forums
- ASX - By Stock
- Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
ahead of our upcoming meeting in March we have provided the FDA...
-
- There are more pages in this discussion • 218 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
97.5¢ |
Change
-0.050(4.88%) |
Mkt cap ! $1.127B |
Open | High | Low | Value | Volume |
$1.03 | $1.04 | 97.0¢ | $6.495M | 6.488M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 21321 | 97.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
98.0¢ | 87032 | 26 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 23552 | 0.975 |
20 | 326539 | 0.970 |
15 | 126157 | 0.965 |
15 | 122898 | 0.960 |
9 | 131529 | 0.955 |
Price($) | Vol. | No. |
---|---|---|
0.980 | 87032 | 26 |
0.985 | 89043 | 13 |
0.990 | 84534 | 18 |
0.995 | 30267 | 5 |
1.000 | 108107 | 14 |
Last trade - 14.23pm 24/06/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |